Skip to content
The Policy VaultThe Policy Vault

Tecfidera (brand)Medica

multiple sclerosis

Preferred products

  • generic dimethyl fumarate delayed-release capsules

Initial criteria

  • Patient meets the standard Multiple Sclerosis – Dimethyl Fumarate Prior Authorization Policy criteria; AND
  • Patient meets BOTH of the following (i and ii):
  • i. Patient has tried generic dimethyl fumarate delayed-release capsules [documentation required]; AND
  • ii. Patient cannot continue to use generic dimethyl fumarate delayed-release capsules due to a formulation difference in inactive ingredient(s) which per the prescriber would result in significant allergy or serious adverse reaction [documentation required].

Approval duration

1 year